AptaBio Therapeutics Dividend
Dividend criteria checks 0/6
AptaBio Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
0%
Buyback Yield
Total Shareholder Yield | 0% |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend updates
No updates
Recent updates
AptaBio Therapeutics (KOSDAQ:293780) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Oct 29Is AptaBio Therapeutics (KOSDAQ:293780) Using Too Much Debt?
Jul 12Here's Why AptaBio Therapeutics (KOSDAQ:293780) Can Manage Its Debt Despite Losing Money
Mar 26Do Institutions Own AptaBio Therapeutics Inc. (KOSDAQ:293780) Shares?
Feb 23Companies Like AptaBio Therapeutics (KOSDAQ:293780) Can Afford To Invest In Growth
Jan 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if A293780's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A293780's dividend payments have been increasing.
Dividend Yield vs Market
AptaBio Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (A293780) | n/a |
Market Bottom 25% (KR) | 1.2% |
Market Top 25% (KR) | 3.7% |
Industry Average (Biotechs) | 0.5% |
Analyst forecast (A293780) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate A293780's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A293780's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A293780's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A293780 has not reported any payouts.